Dr. Thierry M. Muanza
Claim this profileJewish General Hospital
Area of expertise
Brain Tumor
Thierry M. Muanza has run 3 trials for Brain Tumor. Some of their research focus areas include:
Breast Cancer
Thierry M. Muanza has run 2 trials for Breast Cancer. Some of their research focus areas include:
Affiliated Hospitals
Jewish General Hospital
Clinical Trials Thierry M. Muanza is currently running
Breast-Conserving Surgery
for Ductal Carcinoma In Situ
To evaluate whether the combination of clinicopathological factors and the use of the Oncotype DX DCIS score can avoid radiation in women with low risk DCIS who have had breast conserving surgery (BCS)
Recruiting
1 award
N/A
4 criteria
Stereotactic Radiosurgery vs. HA-WBRT + Memantine
for Brain Cancer
Stereotactic radiosurgery (SRS) is a commonly used treatment for brain tumors. It is a one-day (or in some cases two day), out-patient procedure during which a high dose of radiation is delivered to small spots in the brain while excluding the surrounding normal brain. Whole brain radiation therapy with hippocampal avoidance (HA-WBRT) is when radiation therapy is given to the whole brain, while trying to decrease the amount of radiation that is delivered to the area of the hippocampus. The hippocampus is a brain structure that is important for memory. Memantine is a drug that is given to help relieve symptoms that can be caused by WBRT, including problems with memory and other mental symptoms. Health Canada, the regulatory body that oversees the use of drugs in Canada, has not approved the sale or use of memantine in combination with WBRT to treat this kind of cancer, although they have allowed its use in this study.
Recruiting
2 awards
Phase 3
More about Thierry M. Muanza
Clinical Trial Related
3 years of experience running clinical trials · Led 6 trials as a Principal Investigator · 3 Active Clinical Trials
Treatments Thierry M. Muanza has experience with
- NovoTTF-100M Device
- NovoTTF-200M Device
- Breast-Conserving Surgery
- No Radiation
- Radiation
- Hippocampal-avoidant (HA-WBRT) Radiotherapy
Breakdown of trials Thierry M. Muanza has run
Brain Tumor
Breast Cancer
Lung Cancer
Brain metastases
Ductal Carcinoma In Situ
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Thierry M. Muanza specialize in?
Thierry M. Muanza focuses on Brain Tumor and Breast Cancer. In particular, much of their work with Brain Tumor has involved Stage IV patients, or patients who are undergoing treatment.
Is Thierry M. Muanza currently recruiting for clinical trials?
Yes, Thierry M. Muanza is currently recruiting for 3 clinical trials in Montreal Quebec. If you're interested in participating, you should apply.
Are there any treatments that Thierry M. Muanza has studied deeply?
Yes, Thierry M. Muanza has studied treatments such as NovoTTF-100M device, NovoTTF-200M device, Breast-Conserving Surgery.
What is the best way to schedule an appointment with Thierry M. Muanza?
Apply for one of the trials that Thierry M. Muanza is conducting.
What is the office address of Thierry M. Muanza?
The office of Thierry M. Muanza is located at: Jewish General Hospital, Montreal, Quebec H3T 1E2 Canada. This is the address for their practice at the Jewish General Hospital.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.